Hedman, Mia <br/><br/>
Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.  [electronic resource] 

 -  Pediatric transplantation  Aug 2007 
 - 481-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1397-3142 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-3046.2007.00690.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anticholesteremic Agents--adverse effects<br/>Biomarkers--blood<br/>Child<br/>Child, Preschool<br/>Cholesterol, HDL--blood<br/>Colorimetry<br/>Coronary Angiography<br/>Coronary Disease--blood<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--blood<br/>Heart Failure--surgery<br/>Heart Transplantation<br/>Humans<br/>Infant<br/>Male<br/>Postoperative Complications<br/>Pravastatin--adverse effects<br/>Prospective Studies<br/>Treatment Outcome<br/>Ultracentrifugation